News, reviews and podcasts from annual scientific meetings and symposiums around the world.
Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and…
Adding abemaciclib to hormonal therapy reduces the risk of cancer recurrence by 25% in patients…
The results from the confirmatory Phase 3 ASCENT study have been announced showing that sacituzumab…
The results of the phase 3 CheckMate 9ER trial have provided a new first-line treatment…
An international research team of Tokyo Medical and Dental University (TMDU) and Harvard Medical School…
Access to cancer medicines is highly unequal across Europe both for new drugs in development…
Delays and cancellation of cancer treatments and other safety measures undertaken to minimise the risk…
‘Social smokers’ are more than twice as likely to die of lung disease and more…
By Erin Burgess, AGITG For 2020, the Australasian Gastro-Intestinal Trials Group (AGITG) Annual Scientific Meeting…
New treatment options for people with advanced or unresectable hepatocellular carcinoma (HCC) may now be…